{"id":33029,"date":"2020-08-11T12:48:57","date_gmt":"2020-08-11T11:48:57","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33029"},"modified":"2023-04-30T22:14:14","modified_gmt":"2023-04-30T21:14:14","slug":"alissa-m-resch","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/biobanking-2019-speakers\/alissa-m-resch\/","title":{"rendered":"Alissa M. Resch"},"content":{"rendered":"
\n\n\t

Dr. Alissa M. Resch<\/h2>\n

Chief Scientific Officer at Coriell Institute for Medical Research<\/h4>\n\t

As head of scientific operations at the Coriell Institute for Medicial Research, Dr. Alissa M. Resch oversees the scientific functions of the institute, including management of the contracts & grants portfolio and oversight of the research and project management teams. Prior to her role as Chief Scientific Officer, Alissa served as Director of Biobanking Operations. Before joining Coriell, Alissa was an Assistant Professor of Genetics and Developmental Biology at the University of Connecticut, where she conducted research in the field of RNA and stem cell biology. Alissa earned her PhD from the University of California, Los Angeles and completed a postdoctoral fellowship in Genomics and Bioinformatics at the National Center for Biotechnology Information (NCBI) at the National Institutes of Health.<\/p>\n

The Coriell Institute for Medical Research is a non-profit research institute based in Camden, New Jersey. Coriell’s mission is to accelerate scientific discovery by generating world class biomaterials and conducting research in biobanking, personalized medicine, and stem cell biology.<\/p>\n\t\t\t\t\t\t\t\"Alissa_Resch_Coriell_Biotech_Pharma_Summit_2\"\t\t\t\t\t\t\t\n

\n\tTitle: The Evolving Role of Biobanks: Developing Metrics to Identify Future Needs\n\t<\/h3>\n